Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"Hee Kyung Kim"

Article category

Keywords

Publication year

"Hee Kyung Kim"

Original Article

Steatotic liver disease

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
Young Seok Kim, Eun Sun Jung, Wonhee Hur, Si Hyun Bae, Jong Young Choi, Myeong Jun Song, Chang Wook Kim, Se Hyun Jo, Chang Don Lee, Young Sok Lee, Sang Wook Choi, Jin Mo Yang, Jeong Won Jang, Sang Gyune Kim, Seung Won Jung, Hee Kyung Kim, Hee Bok Chae, Seung Kew Yoon
Clin Mol Hepatol 2013;19(2):120-130.
Published online June 27, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.2.120
Background/Aims

The aims of this study were (1) to identify the useful clinical parameters of noninvasive approach for distinguishing nonalcoholic steatohepatitis (NASH) from nonalcoholic fatty liver disease (NAFLD), and (2) to determine whether the levels of the identified parameters are correlated with the severity of liver injury in patients with NASH.

Methods

One hundred and eight consecutive patients with biopsy-proven NAFLD (age, 39.8±13.5 years, mean±SD; males, 67.6%) were prospectively enrolled from 10 participating centers across Korea.

Results

According to the original criteria for NAFLD subtypes, 67 patients (62.0%) had NASH (defined as steatosis with hepatocellular ballooning and/or Mallory-Denk bodies or fibrosis ≥2). Among those with NAFLD subtype 3 or 4, none had an NAFLD histologic activity score (NAS) below 3 points, 40.3% had a score of 3 or 4 points, and 59.7% had a score >4 points. Fragmented cytokeratin-18 (CK-18) levels were positively correlated with NAS (r=0.401), as well as NAS components such as lobular inflammation (r=0.387) and ballooning (r=0.231). Fragmented CK-18 was also correlated with aspartate aminotransferase (r=0.609), alanine aminotransferase (r=0.588), serum ferritin (r=0.432), and the fibrosis stage (r=0.314). A fragmented CK-18 cutoff level of 235.5 U/L yielded sensitivity, specificity, and positive and negative predictive values of 69.0%, 64.9%, 75.5% (95% CI 62.4-85.1), and 57.1% (95% CI 42.2-70.9), respectively, for the diagnosis of NASH.

Conclusions

Serum fragmented CK-18 levels can be used to distinguish between NASH and NAFL. Further evaluation is required to determine whether the combined measurement of serum CK-18 and ferritin levels improves the diagnostic performance of this distinction.

Citations

Citations to this article as recorded by  Crossref logo
  • Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective
    Swasthika Gurjar, Ramanarayana Bhat A, Raghavendra Upadhya, Revathi P. Shenoy
    Lipids in Health and Disease.2025;[Epub]     CrossRef
  • Cytokeratin 18 fragment in liver inflammation and fibrosis: Systematic review and meta-analysis
    Junzhao Ye, Jiaming Lai, Ling Luo, Ting Zhou, Yanhong Sun, Bihui Zhong
    Clinica Chimica Acta.2025; 569: 120147.     CrossRef
  • A Comprehensive Review on the Therapeutic Effects of Salvia hispanica L. (Chia) on Metabolic Dysfunction–Associated Fatty Liver Disease: Special Focus on Pathogenesis
    Maryam Parimi, Sara Arefhosseini, Helda Tutunchi, Seyed Rafie Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Marta Laranjo
    International Journal of Clinical Practice.2025;[Epub]     CrossRef
  • Thyroid hormone Beta receptor agonists for treatment of kidney disease: A promising agent?
    Sidar Copur, Furkan Yavuz, Mehmet Kanbay
    European Journal of Clinical Investigation.2023;[Epub]     CrossRef
  • Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study
    Huai Zhang, Rafael S. Rios, Jerome Boursier, Rodolphe Anty, Wah-Kheong Chan, Jacob George, Yusuf Yilmaz, Vincent Wai-Sun Wong, Jiangao Fan, Jean-François Dufour, George Papatheodoridis, Li Chen, Jörn M. Schattenberg, Junping Shi, Liang Xu, Grace Lai-Hung
    Chinese Medical Journal.2023; 136(3): 341.     CrossRef
  • From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
    Andrea Boccatonda, Lorenzo Andreetto, Damiano D’Ardes, Giulio Cocco, Ilaria Rossi, Susanna Vicari, Cosima Schiavone, Francesco Cipollone, Maria Teresa Guagnano
    Biomedicines.2023; 11(3): 883.     CrossRef
  • Crosstalk between kidney and liver in non-alcoholic fatty liver disease: mechanisms and therapeutic approaches
    Nisha Sharma, Anannya Sircar, Hans-Joachim Anders, Anil Bhanudas Gaikwad
    Archives of Physiology and Biochemistry.2022; 128(4): 1024.     CrossRef
  • Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
    Sina Ghandian, Rahul Thapa, Anurag Garikipati, Gina Barnes, Abigail Green‐Saxena, Jacob Calvert, Qingqing Mao, Ritankar Das
    JGH Open.2022; 6(3): 196.     CrossRef
  • Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review
    Huanqiu Wang, Ruyu Sun, Sisi Yang, Xueqing Ma, Chengbo Yu
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Heterogeneity of non-alcoholic fatty liver disease (NAFLD): Implication for cardiovascular risk stratification
    Francesco Baratta, Laura D'Erasmo, Simone Bini, Daniele Pastori, Francesco Angelico, Maria Del Ben, Marcello Arca, Alessia Di Costanzo
    Atherosclerosis.2022; 357: 51.     CrossRef
  • Serum ferritin level as a noninvasive marker for detection and staging of hepatocellular injury, liver fibrosis, and steatosis in children and adolescents with nonalcoholic fatty liver disease
    Ahmed A. Hassan, Mohiee E.-D.A. El-Aziz Awad, Hanan H. Soliman, Reda A.F. Usef, Dina S. Ata
    Alexandria Journal of Pediatrics.2021; 34(3): 253.     CrossRef
  • Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis
    Jenny Lee, Yasaman Vali, Jérôme Boursier, Kevin Duffin, Joanne Verheij, M. Julia Brosnan, Koos Zwinderman, Quentin M. Anstee, Patrick M. Bossuyt, Mohammad Hadi Zafarmand, Pavel Strnad
    PLOS ONE.2020; 15(9): e0238717.     CrossRef
  • Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
    Jung Gil Park, Gyeonghwa Kim, Se Young Jang, Yu Rim Lee, Eunhye Lee, Hye Won Lee, Man-Hoon Han, Jae Min Chun, Young Seok Han, Jun Sik Yoon, Min Kyu Kang, Young Oh Kweon, Won Young Tak, Soo Young Park, Keun Hur
    Life.2020; 10(10): 230.     CrossRef
  • Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis
    Pauline Verhaegh, Roisin Bavalia, Bjorn Winkens, Ad Masclee, Daisy Jonkers, Ger Koek
    Clinical Gastroenterology and Hepatology.2018; 16(6): 837.     CrossRef
  • Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
    Chris Estes, Homie Razavi, Rohit Loomba, Zobair Younossi, Arun J. Sanyal
    Hepatology.2018; 67(1): 123.     CrossRef
  • Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
    Chris Estes, Quentin M. Anstee, Maria Teresa Arias-Loste, Heike Bantel, Stefano Bellentani, Joan Caballeria, Massimo Colombo, Antonio Craxi, Javier Crespo, Christopher P. Day, Yuichiro Eguchi, Andreas Geier, Loreta A. Kondili, Daniela C. Kroy, Jeffrey V.
    Journal of Hepatology.2018; 69(4): 896.     CrossRef
  • Wet Biomarker-Based Assessment of Steatosis, Inflammation, and Fibrosis in NAFLD
    Peter Lykke Eriksen, Karen Louise Thomsen, Tea Lund Laursen, Konstantin Kazankov, Sara Heebøll, Henning Grønbæk
    Current Hepatology Reports.2017; 16(4): 308.     CrossRef
  • Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD
    Rosa Lombardi, Giuseppina Pisano, Silvia Fargion
    International Journal of Molecular Sciences.2016; 17(4): 548.     CrossRef
  • NAFLD and Chronic Kidney Disease
    Morgan Marcuccilli, Michel Chonchol
    International Journal of Molecular Sciences.2016; 17(4): 562.     CrossRef
  • Evaluation of Serum Perforin, Caspase-3, sFasL and M-30 Levels as Apoptotic Markers in Children With Crimean-Congo Hemorrhagic Fever
    Ahmet S. Güven, Enver Sancakdar, Elif B. Uysal, Ali Kaya, Mehmet B. Oflaz, Hekim Karapinar, Fatih Bolat, Nevin Tuzcu, Köksal Deveci, Ömer Cevit, Füsun D. İcagasioglu
    Pediatric Infectious Disease Journal.2015; 34(2): 208.     CrossRef
  • The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis
    Chuan Shen, Cai-Yan Zhao, Wei Wang, Ya-Dong Wang, Hui Sun, Wei Cao, Wei-Yan Yu, Li Zhang, Ru Ji, Meng Li, Jian Gao
    BMC Gastroenterology.2014;[Epub]     CrossRef
  • Clinical Correlation between Serum Cytokeratin-18 and Metabolic Parameters in Patients with Sonographic Non-alcoholic Fatty Liver Disease
    Dong Shin Kwak, Dae Won Jun, Yong Kyun Cho, Seung Min Lee, Se Hwan Lee, In Sub Jung, Sung Won Lee, Jae Keun Park, JungHoon Lee, Eun Young Lee, Min Rho, Kang Lok Lee, Jun Kwon Ko, Soon-Eung Park
    The Korean Journal of Gastroenterology.2014; 64(4): 206.     CrossRef
  • Comparison on the Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid in Patients with Abnormal Alanine Aminotransferase: Multicenter, Double-blinded, Randomized, Active-controlled Clinical Trial
    Sae Hwan Lee, Gab Jin Cheon, Hong Soo Kim, Young Don Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
    The Korean Journal of Gastroenterology.2014; 64(1): 31.     CrossRef
  • The Clinical Significance of Serum Ferritin in Pediatric Non-Alcoholic Fatty Liver Disease
    Ji Hoon Na, So Won Park, Yunkoo Kang, Hong Koh, Seung Kim
    Pediatric Gastroenterology, Hepatology & Nutrition.2014; 17(4): 248.     CrossRef
  • The Wide and Complex Field of NAFLD Biomarker Research: Trends
    Erika Wichro, Tanja Macheiner, Jasmin Schmid, Barbara Kavsek, Karine Sargsyan
    ISRN Hepatology.2014; 2014: 1.     CrossRef
  • Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
    Giovanni Musso, Roberto Gambino, James H. Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya, Jacob George, Francisco Barrera, Svanhildur Hafliðadóttir, Einar
    PLoS Medicine.2014; 11(7): e1001680.     CrossRef
  • Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis
    Goh Eun Chung, Donghee Kim
    Clinical and Molecular Hepatology.2013; 19(2): 116.     CrossRef
  • 14,640 View
  • 99 Download
  • Crossref
Liver Pathology
Cholangiocarcinoma arising in von Meyenburg complexes
Hee Kyung Kim, So-Young Jin
Korean J Hepatol 2011;17(2):161-164.
Published online June 23, 2011
DOI: https://doi.org/10.3350/kjhep.2011.17.2.161

Citations

Citations to this article as recorded by  Crossref logo
  • Cystic Hepatic Lesions: A Concise Review of Literature
    Anu Abraham, Varsha Prakash, Akhila Aravind, Neha Varshney
    International Journal of Surgical Pathology.2026;[Epub]     CrossRef
  • Intrahepatic cholangiocarcinoma developing from biliary hamartomas: A case report and literature review
    Olfa Ghannei, Soumaya Ben Amor, Mayada Trimech
    International Journal of Surgery Case Reports.2025;[Epub]     CrossRef
  • Ductal Plate Malformation Revisited: biliary lesions from polycystic hepatorenal disease. An educational review.
    Manuel Romero-Martínez, Alberto Gómez Gómez, Marcos Sánchez Martínez, José A. Pons, Juan Egea Valenzuela, Fernando Alberca
    Revista Española de Enfermedades Digestivas.2025;[Epub]     CrossRef
  • A rare encounter - Unveiling the mysteries of biliary hamartoma: A case report
    Deepika C.A., Poornachandra Thejeswi, Shivananda Prabhu, Jyothi Kini
    International Journal of Surgery Case Reports.2024;[Epub]     CrossRef
  • Von Meyenburg complexes mimicking liver metastases of cholangiocarcinoma
    Marta Urzay Gutiérrez, María Victoria Vieiro Medina, Santos Jiménez de los Galanes Marchán
    Journal of Gastrointestinal Surgery.2024; 28(2): 191.     CrossRef
  • Multiple biliary microhamartomas diagnosed in an unsuspecting elderly patient
    Marina Balbino, Manuela Montatore, Giacomo Fascia, Ruggiero Tupputi, Federica Masino, Gianmichele Muscatella, Domenico Mannatrizio, Giuseppe Guglielmi
    Digital Diagnostics.2024; 5(2): 334.     CrossRef
  • Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF)
    Cindy Neuzillet, Marie Decraecker, Hélène Larrue, Line C. Ntanda‐Nwandji, Louise Barbier, Sandrine Barge, Arthur Belle, Carine Chagneau, Julien Edeline, Catherine Guettier, Florence Huguet, Jérémie Jacques, Brigitte Le Bail, Sarah Leblanc, Maïté Lewin, Da
    Liver International.2024; 44(10): 2517.     CrossRef
  • Multiple biliary duct hamartomas in a cat resulting in a hepatic mass: A case report
    Rachel Naghi, Judith Bertran, Elisa Spoldi, Michael J. Dark, Helena Hauck de Oliveira, Carlos Souza, Elizabeth A. Maxwell
    Veterinary Medicine and Science.2023; 9(4): 1441.     CrossRef
  • A CASE REPORT OF VON MEYENBURG COMPLEXES
    V. Hadzhiminev, A. Sarpanov, G. E. Markov, K. Kalacheva, B. Atanasov, V. Belovezhdov V. Belovezhdov
    Trakia Journal of Sciences.2023; 21(1): 69.     CrossRef
  • INTRAHEPATIC BILIARY PROLIFERATIONS: HISTOPATHOLOGY AND POTENTIAL IMMUNOHISTOCHEMICAL MARKERS
    André Bubna HIRAYAMA, Evandro Sobroza de MELLO, Venâncio Avancini Ferreira ALVES
    Arquivos de Gastroenterologia.2023; 60(3): 393.     CrossRef
  • Intrahepatic Cholangiocarcinoma Arising from Biliary Hamartomas in Patients with Recurrent Acute Cholangitis: A Case Report and Literature Review
    Sang Min Lee, Ki Bae Kim, Joung-Ho Han, Chang Gok Woo, Hee Bok Chae, Seon Mee Park
    The Korean Journal of Gastroenterology.2023; 82(3): 145.     CrossRef
  • Biliary Duct Hamartomas: A Systematic Review
    Abdul Ahad E Sheikh, Anthony P Nguyen, Katarina Leyba, Nismat Javed, Sana Shah, Alexander Deradke, Christopher Cormier, Rahul Shekhar, Abu Baker Sheikh
    Cureus.2022;[Epub]     CrossRef
  • A Case of Multicystic Biliary Hamartoma Treated with Left Medial Sectionectomy
    Naomi KUROKI, Tomoaki TANAKA, Takanobu SUGASE, Syoji TANIGUCHI, Takashi GOTO, Rintaro KOGA, Takumi KIWAKI, Hiroyuki TANAKA
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2022; 83(2): 395.     CrossRef
  • Zystische Leberläsionen – Diagnostik und Therapieoptionen
    Jonas Babel, Sebastian Rademacher, Timm Denecke, Daniel Seehofer
    Allgemein- und Viszeralchirurgie up2date.2021; 15(05): 407.     CrossRef
  • Ductal Plate Malformations in Captive Snakes
    Olivia M. Patania, Brigid V. Troan, John M. Cullen
    Veterinary Pathology.2021; 58(4): 736.     CrossRef
  • A Case Report of Cholangiocarcinoma Arising from a Biliary Adenofibroma: Radiologic Findings and Review of Literature
    Hyun-Ji Lim, Mi-Suk Park, Young Nyun Park, Sun Il Kim, Yeo-Eun Kim, Cheong Hoon Hwang
    Journal of the Korean Society of Radiology.2021; 82(3): 721.     CrossRef
  • Von Meyenburg Complexes Mimicking Diffuse Metastatic Liver Disease
    Nikolaos S. Salemis, Ilias Katikaridis, Andreas Zografidis
    Journal of Gastrointestinal Cancer.2019; 50(4): 972.     CrossRef
  • Bile Duct Hamartoma Mimicking Metastatic Cholangiocarcinoma
    Raymond Elsoueidi, Stephen J. Mularz, Elie M. Richa
    Journal of Gastrointestinal Cancer.2017; 48(1): 87.     CrossRef
  • Multicystic biliary hamartoma with extremely elevated CA19-9: a case report
    Takeshi Morinaga, Katsunori Imai, Yo-Ichi Yamashita, Takanobu Yamao, Takayoshi Kaida, Shigeki Nakagawa, Daisuke Hashimoto, Akira Chikamoto, Shinji Sumiyoshi, Yoshiki Mikami, Hideo Baba
    Scandinavian Journal of Gastroenterology.2017; 52(8): 916.     CrossRef
  • Cystic lesions of the liver—A review
    Maheswaran Pitchaimuthu, Mark Duxbury
    Current Problems in Surgery.2017; 54(10): 514.     CrossRef
  • Surgery is the preferred treatment for bile duct hamartomas
    Xiao-Yu Yang, Hai-Bo Zhang, Bin Wu, Ai-Jun Li, Xiao-Hui Fu
    Molecular and Clinical Oncology.2017; 7(4): 649.     CrossRef
  • Imaging of Von Meyenburg complexes
    L. Pech, S. Favelier, M.T. Falcoz, R. Loffroy, D. Krause, J.P. Cercueil
    Diagnostic and Interventional Imaging.2016; 97(4): 401.     CrossRef
  • Child's von meyenburg complexes
    Anna Makhneva, Bekisheva Aigul, Bulegenova Minira, Adamova Gauhar
    Journal of Histology and Histopathology.2015; 2(1): 15.     CrossRef
  • Malignant Transformation in Von-Meyenburg Complexes
    Vishwas Parekh, Deniz Peker
    Applied Immunohistochemistry & Molecular Morphology.2015; 23(9): 607.     CrossRef
  • Biliary hamartoma presented as a single mass
    Yong Moon Shin
    The Korean Journal of Hepatology.2011; 17(4): 331.     CrossRef
  • 9,286 View
  • 65 Download
  • Crossref